Alx Oncology Holdings Inc

NASDAQ:ALXO   3:59:51 PM EDT
8.78
+0.14 (+1.62%)
Earnings Announcements

ALX Oncology Holdings Q1 GAAP Loss Per Share $0.60

Published: 05/09/2022 21:28 GMT
Alx Oncology Holdings Inc (ALXO) - Alx Oncology Reports First Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights.
Q1 GAAP Loss per Share $0.60.
Q1 Earnings per Share View $-0.71 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.67

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.68

More details on our Analysts Page.